FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease
NCT: NCT05504811 · COMPLETED
Brief Summary
This study will investigate the efficacy of a newly developed exercise device (FitMi AD) for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease. FitMi AD uses embedded sensors that can track and record the patient's direction and degree of movement while performing exercises described on a computer.
Frequently Asked Questions
What is FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease?
FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease is a clinical trial registered under NCT05504811. Current status: COMPLETED.
What is the status of NCT05504811?
The current status of NCT05504811 (FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease) is: COMPLETED.
When did FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease start?
FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease started on 2023-09-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.